Key facts
- This page summarizes Peter Clausen's Form 4 filing for Nuo Therapeutics, Inc. (AURX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Aug 2025, 09:06.
Peter Clausen - 31 Jul 2025 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)
- Reporting relationship
- CSO/COO
- Issuer ticker
- AURX
- Reported as of
- 31 Jul 2025
- Net transaction value
- +$73,541
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2025, 09:06:50 UTC
- Prior SEC filing
- 21 May 2024
- Next SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Jorden, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter Clausen filed Form 4 for Nuo Therapeutics, Inc. (AURX) on 04 Aug 2025.
Change
- Previous filing in this sequence was filed on 21 May 2024.
- Current net transaction value: +$73,541.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001605411
Primary reporting owner
CLAUSEN PETER
- Relationship
- CSO/COO
- Address
- C/O NUO THERAPEUTICS, INC., 8285 EL RIO, SUITE190, HOUSTON
- Signature
- /s/ David Jorden, attorney-in-fact
- Signature date
- 04 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AURX
transaction
Common Stock
Options Exercise
- Transaction value
- $73,541
- Shares
- +183,853
- Change %
- +31%
- Price
- $0.4000
- Shares after
- 770,054
- Date
- 31 Jul 2025
- Ownership
- Direct
AURX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,474
- Date
- 31 Jul 2025
- Ownership
- By spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AURX
transaction
Derivative
Option to purchase common stock
Options Exercise
- Transaction value
- $0
- Shares
- -183,853
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 09 Aug 2018
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 183,853
- Exercise price
- $0.4000
* marks a reported price that did not pass the local price check.